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Abstract: Two strains of Azadinium poporum, one from the Korean West coast and the other 
from the North Sea, were mass cultured for isolation of new azaspiracids. Approximately 
0.9 mg of pure AZA-36 (1) and 1.3 mg of pure AZA-37 (2) were isolated from the Korean 
(870 L) and North Sea (120 L) strains, respectively. The structures were determined to be 
3-hydroxy-8-methyl-39-demethyl-azaspiracid-1 (1) and 3-hydroxy-7,8-dihydro-39-
demethyl-azaspiracid-1 (2) by 1H- and 13C-NMR. Using the Jurkat T lymphocyte cell 
toxicity assay, (1) and (2) were found to be 6- and 3-fold less toxic than AZA-1, respectively. 








The first azaspiracid poisoning (AZP) event was recorded in 1995 after eight people experienced 
severe gastrointestinal disorders following consumption of mussels originating from the Irish West 
Coast. Symptoms were typical of diarrhetic shellfish poisoning (DSP). Even though the mouse 
bioassay for DSP toxicity was also strongly positive, no DSP toxins could be detected at elevated 
levels and thus could not account for the observed severe intoxications [1]. 
In 1998, the causative compound was isolated and characterized from shellfish and subsequently 
named azaspiracid-1 (AZA-1) according to its structural properties [2]. A few years later, the synthesis 
of AZA-1 led to its structural revision [3]. AZAs are polyketides consisting of highly hydroxylated 
linear carbon chains that are cyclized at several points by formation of ether bridges. In addition, 
AZAs typically contain a six-membered cyclic imine ring [2,3]. 
After AZAs were confirmed to be responsible for gastrointestinal disorders associated with the 
consumption of seafood, further AZP incidents were reported from France and Italy [4]. To date, there 
are no systematic global surveys on the geographical distribution of AZAs but there are several reports 
of shellfish contaminated with AZAs, such as from the East coast of England and along the Norwegian 
West Coast [5], Portugal [6], Morocco [7], Chile [8], Japan [9] and China [10]. In contrast, monitoring of 
lipophilic phycotoxins in mussels from the White Sea (Russia) did not indicate the presence of AZAs [11]. 
More than two dozen naturally occurring structural variants of AZA-1 have been described [12]. 
Although most research has focused on AZA-1 as the first discovered and most accessible AZA 
analogue, other structural variants have been isolated and characterized from shellfish [13–16]. 
In 2007, an AZA-producing organism was isolated [17] and identified as Azadinium spinosum [18]. 
Bulk culturing of this organism was performed with subsequent isolation of AZA-1, -2 [19], -33  
and -34 and description of AZA-35 [20]. In addition to A. spinosum, a number of new species of the 
genus Azadinium were described from the North Sea: A. obesum [21], A. poporum [22], and  
A. polongum [23]. A species designated as A. cf. spinosum was reported to form blooms at the 
Argentinean shelf [24], A. dexteroporum was described from the Mediterranean [25], A. dalianense 
from the coast of China [26], and more recently three new species have been described from the 
Irminger Sea (North Atlantic) [27]. In addition to the European strains of A. poporum, there also exists 
a strain from Korean coastal waters [28] and a number of strains from China [29]. Based on minor 
differences in shape of the 3′ plate and variability in ribosomal DNA sequences between the Korean 
and the European strains, the Korean isolate was initially designated as A. cf. poporum. However, this 
trait was subsequently shown to vary among and within other Asian A. poporum strains [29], which 
supports the notion that A. poporum from Europe and Asia, despite their differences in ITS and 28S 
gene sequences [29], are conspecific. Most species of the genus Azadinium were originally described 
as non-AZA producers [21–23,26]. However, in various strains of A. poporum we recently detected 
compounds that show fragmentation patterns with high similarities to those of AZAs. Based on 
collision induced dissociation (CID) spectra and high resolution mass spectral analysis, putative 
molecular structures for these new toxins were proposed [30]. 
In this study, the structures of these compounds were verified using nuclear magnetic resonance 
(NMR) spectroscopy and their in vitro potencies were obtained using the Jurkat T lymphocyte cell assay. 
  




2.1. Purification of AZA-36 (1) and AZA-37 (2) 
We purified AZA-36 (1) and AZA-37 (2) from two strains of A. poporum, one from the Western 
Pacific [28] and the other from the North Sea [22] using procedures previously described [19].  
Four isolation steps were required to purify (1) from the HP20 extracts (Table 1). For (1) a relatively 
high amount of culture (870 L) was needed for a final yield of 0.89 mg, because the toxin cell quota of 
the Korean strain of A. poporum with ~2 fg·cell−1 was relatively low [30]. 
Table 1. Batch summary table for purification of AZA-36 (1). 
Step No Step AZA-36 [mg] Weight [g] Purity [%] † 
 HP20 resin extract 1.30 8.30 <0.1 
1 Ethyl acetate partitioning 1.20 0.74 0.2 
2 Silica gel 1.05 0.18 0.6 
3 Flash (phenyl-hexyl) 0.92 <0.01 40.0 
4 Prep HPLC (C18) 0.89 - > 95 
 % Recovery (steps 1−4) 69   
† Based on w/w. 
In contrast to the Korean strain, the North Sea strain had an approximately tenfold (2) cell quota of 
~20 fg·cell−1 [30] and thus only 120 L of culture were needed to give a final amount of 1.28 mg  
pure (2) (Table 2). 
Table 2. Batch summary table for purification of AZA-37 (2). 
Step No Step AZA-37 [mg] Weight [g] Purity [%]† 
 HP20 resin extract 1.70 1.03 0.2 
1 Silica gel 1.60 0.25 0.6 
2 Flash (phenyl-hexyl) 1.57 0.01 20.0 
3 Prep HPLC (C18) 1.28 - >95 
 % Recovery (steps 1−3) 75   
† Based on w/w. 
2.2. Structure Elucidation of AZA-36 (1) and AZA-37 (2) 
The chemical shifts (1H and 13C) of (1) and (2) are listed in Table 3. The corresponding spectra are 
given as supplementary material. Compared to AZA-1, the 1H-NMR spectrum of (1) (Table 3) showed 
an extra oxymethine signal at δ 4.43, an allylic methyl signal at δ 1.70, and the loss of the 39-methyl 
signal. The 1H,1H-COSY correlations between H-2/H-3 and H-3/H-4 confirmed the neighborhood of 
H-2 and H-4 to the oxymethine (H-3). The 13C signal of C-3 at δ 71.4 indicated that C-3 of (1) was 
substituted by a hydroxyl group. The 1H,13C-HMBC spectrum showed correlations from H-47 (δ 1.70) 
to C-7 (123.4), C-8 (132.1), and C-9 (41.1), and the 1H,1H-COSY spectrum showed correlations 
between H-47/H-7 (δ 5.36) and H-47/H-6 (δ 4.79). These correlations allowed the assignment of the 
new allylic methyl group. Moreover, the methyl group at C-39 was substituted by a proton according to the 
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1H,1H-COSY spectrum. The other subunits in (1) were assigned on the basis of the 1D and  
2D NMR experiments. Based on these results, the structure of AZA-36 was deduced to be  
3-hydroxy-8-methyl-39-demethyl-azaspiracid-1 (1), as shown in Figure 1. 
Table 3. 1H- and 13C-NMR chemical shifts of AZA-36 (1) and AZA-37 (2). 
Atom No. 
AZA-36 AZA-37 
δC δH δC δH 
1 180.3 a - - 180.3 a - - 
2 46.0 2.34 2.39 46.1 2.33 - 
3 71.4 4.43 - 71.4 4.39 - 
4 135.5 5.75 - 134.6 5.70 - 
5 132.1 5.64 - 133.1 5.65 - 
6 72.8 4.79 - 73.3 4.35 - 
7 123.4 5.36 - 38.4 1.43 1.87 
8 132.1 - - 22.2 1.70 1.77 
9 41.1 2.00 2.44 36.6 1.70 1.83 
10 108.3 - - 109.1 - - 
11 34.0 1.71 2.33 33.9 1.69 2.33 
12 38.3 1.99 2.18 32.8 1.83 2.03 
13 112.2 - - 111.8 - - 
14 32.1 2.02 - 31.8 2.01 - 
15 33.3 1.76 1.86 33.5 1.76 1.87 
16 78.9 3.91 - 78.9 3.94 - 
17 74.2 4.23 - 74.3 4.29 - 
18 37.5 1.99 2.06 37.6 2.00 2.07 
19 79.9 4.43 - 79.9 4.44 - 
20 77.5 3.90 - 77.4 3.93 - 
21 101.1 - - 101.0 - - 
22 37.8 2.06 - 37.6 2.07 - 
23 39.1 1.44 1.44 39.1 1.43 1.43 
24 43.0 1.35 - 43.0 1.35 - 
25 80.4 4.00 - 80.3 4.00 - 
26 149.0 - - 149.0 - - 
27 50.4 2.26 2.43 50.4 2.25 2.42 
28 99.4 - - 99.4 - - 
29 45.0 1.37 2.05 45.0 1.36 2.05 
30 27.2 2.23 - 27.2 2.23 - 
31 36.2 1.52 1.83 36.1 1.52 1.84 
32 73.7 4.37 - 73.7 4.37 - 
33 82.1 4.05 - 82.1 4.05 - 
34 75.7 4.99 - 75.7 5.00 - 
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Table 3. Cont. 
35 42.8 2.49 2.61 42.7 2.49 2.60 
36 98.0 - - 98.0 - - 
37 37.5 1.99 - 36.7 1.98 - 
38 29.8 1.61 1.68 29.7 1.63 1.67 
39 23.8 1.70 1.81 23.8 1.70 - 
40 41.3 2.98 3.17 41.2 2.99 3.17 
41 17.5 0.94 - 17.5 0.90 - 
42 17.2 0.92 - 17.2 0.92 - 
43 18.9 0.84 - 18.9 0.84 - 
44 117.8 5.16 5.33 117.8 5.15 5.33 
45 24.3 0.96 - 24.3 0.96 - 
46 16.4 0.98 - 16.4 0.97 - 
47 23.0 1.70 - - - - 
a Chemical shift value obtained from the 1H,13C-HMBC spectrum because the signal was not observed in the 
1D 13C spectrum. 
 
Figure 1. Structures of AZA-1 (top), AZA-36 (1) (bottom, left), and AZA-37 (2) (bottom, right). 
The 13C-NMR spectrum of (2) showed four olefinic carbons in total, which are two less compared 
to AZA-1. After examination of the NMR spectra, it was concluded that the four olefinic carbons of 
(2) (C-4, C-5, C-26, and C-44) remained the same as in AZA-1. Therefore, the last double bond of 
AZA-1 at C-7/C-8 is a single bond in (2). Moreover, the new oxymethine signal at δ 4.39 and loss of 
the 39-Me signal were also observed from the 1H-NMR spectrum. These data suggested the same 
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hydroxylated carbon C-3 and the proton substituted methyl group at C-39 in (1). Therefore, the 
structure of AZA-37 was confirmed to be 3-hydroxy-7,8-dihydro-39-demethyl-azaspiracid-1 (2), as 
shown in Figure 1. 
2.3. Cytotoxicity 
The toxicity of (1) and (2) was assessed using the Jurkat T lymphocyte cell assay. In order to 
compare this data to the known toxicities of other AZAs, AZA-1 was included in this assay and 
individual toxicities were expressed as relative potencies. Similar to AZA-1, (1) and (2) elicited 
concentration- and time-dependent cytotoxic effects towards T lymphocytes but with variable 
potencies, clearly seen from the dose-response curves of the three compounds (Figure 2). The 
cytotoxic effects induced by AZA-1 are consistent with previously published studies [31–33]. 
 
Figure 2. Effect on T lymphocyte cell viability. Jurkat T cells exposed to various 
concentrations of (A) AZA-1; (B) AZA-36 (1); and (C) AZA-37 (2) for 24, 48, or 72 h and 
viability assessed using the MTS assay. All data (mean ± SE; n = 4) were normalized to the 
control (10% methanol vehicle). Non-linear, three parameter dose-response (variable 
slope) analysis was performed and EC50 values were calculated (Table 4). 
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The steep slopes illustrate the narrow toxicological window and the step-wise decrease in viability 
with longer exposure times (at the higher concentrations) may represent the irreversible nature of the 
AZAs [34]. Compound (1) was found to be the least toxic with a relative (to AZA-1) toxicity of 16% 
(mean EC50:1.70 nM) while (2) had a relative toxicity of 33% (mean EC50: 0.85 nM) (Table 4). 
Table 4. Calculated EC50 values (with 95% confidence intervals) and relative potencies for 
AZA-1, AZA-36 (1), and AZA-37 (2) based on a T lymphocyte cytotoxicity assay. 
AZA 
Analogue 
24 h 48 h 72 h Mean  
EC50 [nM] 
Rel. Pot.
EC50 [nM] 95% CI EC50 [nM] 95% CI EC50 [nM] 95% CI 
AZA-1 0.22 0.10–0.49 0.34 0.18–0.65 0.27 0.14–0.52 0.28 1 
AZA-36* (1) 1.9 0.89–4.1 1.5 0.92–2.4 1.7 0.92–3.2 1.70 0.16 
AZA-37 (2) 0.91 0.27–3.1 0.82 0.51–1.3 0.82 0.46–1.5 0.85 0.33 
* Data corrected for 97% purity. 
3. Discussion 
For many years, the causative organism responsible for the production of AZAs went unidentified. 
Since the discovery of A. spinosum in 2007, many new species have been identified. However, 
production of AZAs and the diversity and uniqueness of the various analogues has not yet been fully 
characterized for some of the recently identified Azadinium species. In the original species description, 
A. poporum was considered as non-toxic [22], but recent research showed that this dinoflagellate is 
capable of producing AZAs [30]. However, initial mass spectral data indicated that some of the AZAs 
produced by A. poporum were structurally unique from previously reported analogues by having a 
modification of the nitrogen-containing I-ring of the molecule [29,30,35]. The sum formula of (1) had 
previously been determined by high resolution mass spectrometry as C47H72NO13 and the elemental 
composition of (2) had been determined as C46H72NO13 [30]. Mass spectral interpretations of collision 
induced dissociation spectra allowed for the above mentioned structural predictions. However, these 
predictions are limited by the fact that mass spectrometry only yields the m/z ratios of the fragments. 
Thus, mass spectrometry cannot differentiate between isomeric partial structures and full structural 
elucidation must be achieved by NMR. However, unlike mass spectrometry, NMR requires pure 
compounds in relatively high amounts (typically between 100 and 1000 µg). For this reason, we 
purified (1) and (2) from two strains of A. poporum, one from the western Pacific [28] and the other 
from the North Sea [22]. The standard procedure of extracting harvested cells with organic solvents 
results in extracts contaminated with a high proportion of matrix compounds, which require many 
purification steps. In the current study, the extraction protocol included acetone for cell lysis followed 
by the (SPATT) technique [36] for the extraction of AZAs. This approach was used previously by 
Jauffrais et al. [19] to harvest AZAs from the permeate and non-retentate phases following bulk 
culturing of A. spinosum in photobioreactors. The procedure does not require centrifugation or cell 
filtration steps, which makes it much more feasible. Only four isolation steps were required to purify 
(1) from the HP20 extracts. In contrast, for the isolation of (2) only three purification steps were 
necessary and the ethyl acetate-water liquid-liquid partitioning used in the purification of (1) could be 
omitted. Accordingly, (2) was purified by silica chromatography, flash chromatography, and 
preparative reversed phase chromatography (Table 2). 
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3.1. Structure Elucidation of AZA-36 (1) and AZA-37 (2) 
The results of the NMR investigation did not entirely confirm the originally proposed structures of 
(1) and (2) which were solely based on mass spectral experiments. The structural element that was 
confirmed is the 39-demethylation of the I-ring in both compounds in comparison to the parent compound 
AZA-1 (Figure 1). However, the NMR measurements of this study revealed that the hydroxylation site 
of both (1) and (2) is located at C-3 instead of the initially proposed C-2 position. In addition, the 
methyl group of the side chain/A-ring fragment of (1) is now known to be located at the C-8 position 
(instead of the initially proposed C-3 position), a feature shared by both (1) and AZA-2. Thus, we 
could unambiguously assign the structure of 3-hydroxy-8-methyl-39-demethyl-azaspiracid-1 to (1). 
The structural elements of (2), which could be confirmed by NMR, are the above-mentioned  
39-demethylation and additionally the 7,8-dihydration. However, the originally suggested 2-hydroxylation 
is now known to be at the C-3 position and the 3-methylation at C-14 in the C-ring. Collectively, (2) is 
structurally elucidated as 3-hydroxy-7,8-dihydro-39-demethyl-azaspiracid-1 (Figure 1). It is noteworthy 
that both compounds, with the exception of the 39-demethylation, only show modifications in the side 
chain and A-ring of the molecule, which is the putative biosynthetic end of AZAs [37]. 
3.2. Cytotoxicity 
Our cytotoxicity assays indicated that (1) and (2) are 6- and 3-fold less toxic than AZA-1 
respectively. Both, (1) and (2) differ from AZA-1 in the lack of the 39-methyl group and in the 
additional 3-hydroxyl group. Most likely one of the two or even both structural elements seem to have 
an influence on the toxic potency in the T lymphocyte cell model system. Using the same cytotoxicity 
method with T lymphocyte cells, the relative cytotoxic potencies of naturally isolated AZA-1, AZA-2, 
and AZA-3 towards T lymphocytes was AZA-2 > AZA-3 > AZA-1 [31] strongly suggesting that 
methylation at the C-8 and C-22 positions play a role in determining the toxicity. Although the 
toxicophore of the AZA molecule has not yet been identified, the A/B/C ring region of the AZA 
molecule is highly important for maintained cytotoxicity. AZA-33 with an m/z of 716 (AZA-1 missing 
A/B/C rings) was significantly less potent than AZA-1 (~5-fold), whereas AZA-34 with an m/z of 816 
(AZA-1 missing C4/C5 alkene) was 5.5-fold more potent than AZA-1 [20]. Similarly, an AZA-1 
isomer (37-epi-AZA-1) was 5.1-fold more potent than AZA-1 [38]. Semi-synthetic hydrogenated 
AZA-1 analogues, 4,5-dihydro-AZA-1 and 4,5,7,8-tetrahydro-AZA-1, were also tested. Both 
compounds were found to be approximately equipotent to AZA-1 [32] suggesting that the C4/C5 
alkene and the C7/C8 olefin bonds are not necessary for toxicological activity. 
4. Experimental Section 
4.1. Reagents 
Acetone and methanol used for cell lysis and resin preconditioning were HPLC grade, purchased 
from J.T. Baker (Center Valley, PA, USA). The anion exchange resin (Diaion® HP20) was from 
Supelco® (Steinheim, Germany). All other solvents (pestican grade) were purchased from Labscan 
(Dublin, Ireland). Sodium chloride (>99%), triethylamine (99%), ammonium acetate (>97%), 
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ammonium formate (reagent grade), formic acid (>98%), and silica gel (10–40 µm, type H) were 
purchased from Sigma-Aldrich (Steinheim, Germany). Luna Phenyl-Hexyl (15 µm) was from 
Phenomenex (Cheshire, UK). AZA-1 certified reference material (CRM) was obtained from the NRC, 
Certified Reference Material Program (Halifax, NS, Canada). 
4.2. Cell Culture and Extraction 
A total of 870 L A. poporum strain HJ-2010 (hereafter named “Korea”) isolated as described in [28] 
from Shiwha Bay, a highly eutrophic bay from Korea (37°18′ N, 126°36′ E), and a total of 120 L  
A. poporum strain UTHC8 (hereafter named “North Sea”) isolated from the North Sea [22] were 
cultivated in aerated 10 L batch cultures in F/2 medium-Si [39] (for the Korean isolate) or in a half-strength 
modified K-medium [22] (for the North Sea isolate) in a growth chamber at 20 °C under an 
illumination of 20−50 µE·m−2·s−1 of cool white fluorescent light on a 14:10 h light-dark cycle. 
Cultures were harvested in late stationary phase at cell densities (irregularly checked by manual 
counting using an inverted microscope) ranging from about 1–3 × 105 cell·mL−1. Cells in the culture 
flasks were lysed by addition of acetone (HPLC grade, J.T. Baker, Center Valley, PA, USA) to final 
concentration of 7%. One g·L−1 anion exchange resin (Diaion® HP20, Supelco®, Steinheim, Germany), 
which previously had been preconditioned with methanol (HPLC grade, J.T. Baker, Center Valley, PA, 
USA) for 24 h, was added to the broth. After shaking for 24 h, the resin was then collected on a 100 
µm Nitex mesh, dried, and frozen at −20 °C until extraction. For extraction, 300 g of HP20 resin were 
suspended in 400 mL of methanol and shaken for 2 h on a lab shaker and subsequently partitioned into 
two aliquots. Each aliquot was transferred into a glass chromatography column (3 cm diameter, 60 cm 
length) and was eluted with 500 mL methanol. The column elutes of each strain were reduced in a rotary 
evaporator, combined, and finally taken to dryness. 
4.3. Purification of AZA-36 and AZA-37 
The combined HP20 resin extracts were partitioned between ethyl acetate (150 mL) and aqueous 
NaCl (1 M, 50 mL). The ethyl acetate fraction was evaporated to dryness in vacuo. Approximately 2 g 
of silica gel was added to the dried extract. The sample was mixed to a fine powder and loaded on to a 
silica gel (6 g) column (6 × 4 cm). Vacuum-assisted elution was performed successively with hexane, 
ethyl acetate, ethyl acetate−methanol (9:1, 7:3, and 1:1), and methanol (30 mL of each, all containing 
0.1% acetic acid except for hexane). The methanol fraction, which flow injection analysis  
(FIA)-MS/MS (method A) showed to contain the AZAs, was evaporated in vacuo, and the sample in 
acetonitrile–water (6:4, plus 0.1% triethylamine) was loaded onto a column packed with phenyl-hexyl 
(19.9 × 2 cm). The sample was eluted with acetonitrile–water (3:7, plus 0.1% triethylamine) at  
4 mL·min−1, and 5 mL fractions were collected. Appropriate fractions were combined (fractions 18–25 
for AZA-36 (1) and fractions 17–23 for (2)) based on FIA-MS/MS analysis. 
Final purification was achieved by semi-preparative model 10AVp HPLC (Shimadzu, Kyoto, 
Japan) with photodiode array (PDA) detection (210 nm) using a Cosmosil C18 (5 µm, 250 × 4.6 mm, 
Nacalai tesque, Kyoto, Japan) column eluted with acetonitrile–water (2:3, plus 2 mM ammonium 
acetate) at 1 mL min−1. The column temperature was 30 °C. Purified (1) was recovered by evaporation 
to ~20% acetonitrile, loading on to a SPE cartridge (Oasis HLB, 200 mg), washing with  
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methanol–water (1:9, 10 mL) to remove the buffer, and eluting with methanol–water (4:6, 6:4, 8:2, 
10:0, 20 mL each) with >95% of the AZAs eluting in the 8:2 fraction. Removal of solvent by 
evaporation in vacuo afforded purified (1) and (2) as white solids. 
4.4. LC-MS/MS Analysis 
4.4.1. Method A 
Qualitative analysis of fractions for AZAs was performed by FIA-MS/MS using a Micromass 
(Manchester, UK) QTof Ultima. Samples (2 µL) were injected, using a Waters (Manchester, UK) 
model 2795 LC autosampler, directly (no column) into the mass spectrometer monitoring for the 
precursor ions: (1) m/z 858.5, and (2) m/z 846.5. The cone voltage was 40 V, the cone and desolvation 
gas flows were set at 100 and 800 L·h−1, respectively, and the source temperature was 150 °C. 
4.4.2. Method B 
Recoveries were determined by quantitative analysis (against AZA-1 CRM) of fractions on a 
Waters 2795 LC coupled to a Micromass QTof Ultima operated in precursor ion scan mode monitoring 
for the following masses: AZA-1 m/z 842.5, (1) m/z 858.5, and (2) m/z 846.5. The MS parameters were 
the same as those described in method A. 
An isocratic elution was used, with phase A consisting of water and phase B of 95% acetonitrile in 
water (both containing 2 mM ammonium formate and 50 mM formic acid). Chromatography was 
performed with an ACE C18 column (30 × 2.1 mm, 3 µm) (Advanced Chromatography Solutions, 
Aberdeen, UK). The injection volume was 5 µL and the column and sample temperatures were 25 °C 
and 6 °C, respectively. 
4.4.3. Method C 
Purity was initially assessed on the QTof Ultima by running MS scans (m/z 100–1000) using binary 
gradient chromatographic conditions with phase A consisting of water and phase B of 95% acetonitrile 
in water (both containing 2 mM ammonium formate and 50 mM formic acid). Chromatography was 
performed with a Hypersil BDS C8 column (50 × 2.1 mm, 3 µm, with a 10 × 2.1 mm guard column of 
the same stationary phase) (Thermo Scientific, Waltham, MA, USA). The gradient was from 30% B, 
to 90% B over 8 min at 0.25 mL·min−1, held for 5 min, then held at 100% B at 0.4 mL min−1 for 5 min, 
and returned to the initial conditions and held for 4 min to equilibrate the system. The injection volume 
was 5 µL and the column and sample temperatures were 25 and 6 °C, respectively. Analysis for other 
known AZA analogues was also performed by product ion scans, where the precursor ions were 
selected and then fragmented. 
4.4.4. Method D 
Purity was further assessed by UV analysis. A concentrated sample (~500 µg·mL−1) was injected  
(1 µL) onto the semi preparative system (model 10AVp, Shimadzu, Kyoto, Japan) with photodiode 
array (PDA) detection (210 nm) using a Cosmosil C18 column (5 µm, 250 × 4.6 mm) eluted with 
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acetonitrile–water (2:3, plus 2 mM ammonium acetate) at 1 mL·min−1. The column temperature was  
30 °C. 
4.5. NMR Analysis 
NMR spectra were recorded on an Avance 600 MHz NMR spectrometer (Bruker, Bremen, 
Germany) (600 MHz for 1H, 150 MHz for 13C) equipped with a cryo platform. All experiments were 
measured at 303 K. Compounds (1) and (2) were obtained as white powders and dissolved in 
methanol-d4 (3.31 ppm of residual CH3OH for 1H-NMR and 49.0 ppm for 13C-NMR). The spectra 
were all referred to solvent signals stated accordingly as internal standards. 
4.6. Toxicity Assays 
4.6.1. Cell Culturing 
Human Jurkat E6-1 T lymphocyte cells (American Type Culture Collection TIB-152; Manassas, 
VA, USA) were grown as previously described [31]. Briefly, cells were grown in RPMI-1640 medium  
(cat. #11875-093, Invitrogen, CA, USA) supplemented with 10% (v/v) fetal bovine serum (FBS; cat. 
#26140, Invitrogen, CA, USA) and maintained in a humidified incubator (18AIC-UV, Sanyo, 
Rutherford, NJ, USA) with 5%:95% CO2:air at 37 °C. Cells were subcultured with fresh medium at an 
inoculum ratio of 1:4 every 3 to 4 days by transferring 2.5 mL of cells to 7.5 mL of fresh supplemented 
medium in 75 cm2 screw cap culture flasks. 
4.6.2. Cytotoxicity Assay 
To determine the effect of the AZA analogues on cellular toxicity, Jurkat T lymphocyte cells were 
continuously exposed to toxins and viability determined. Exponentially growing cells were seeded in a 
volume of 100 μL of the supplemented medium at a density of 30,000 cells per well in black, sterile,  
96-well culture plates for 18–24 h to allow for recovery and settling. A range of final AZA 
concentrations were then added for 24, 48, or 72 h of continuous exposure prior to assessment of 
cytotoxicity. Parallel controls of equivalent amounts of methanol/PBS were used to normalize the 
viability data for each treatment. Cellular viability/cytotoxicity was assessed using the MTS  
(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) assay 
(Promega Biosciences, San Luis Obispo, CA, USA; cat. no. G5421). Like other tetrazolium-based 
assays, MTS in the presence of an electron coupling reagent (phenazine methosulfate; PMS) measures 
cellular viability by determining the activity of mitochondrial dehydrogenases [40]. As a substrate for 
dehydrogenases, MTS becomes reduced into a soluble, purple dye that can be quantified 
colourimetrically to determine the relative level of cellular viability/cytotoxicity per well. Following 
exposure of the cells to the AZA analogues for a specified period of time, each well received 10 μL of 
a PMS/MTS (1:20) solution. Cells were incubated for 4 h after which absorbance readings at 485 nm 
were obtained using a FluoStar microplate reader (BMG Lab Technologies, Cary, NC, USA). Data are 
presented as means ± SE of three separate experiments (n = 3 biological replicates). In addition, within 
each experiment, every concentration of each AZA analogue was tested in duplicate wells. 
Cytotoxicity data were blank corrected and normalized to the control (% viability). EC50 and 95% 
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confidence interval determinations were calculated using three parameter, variable slope,  
non-linear regression analysis (GraphPad Prism, ver. 5.0f, San Diego, CA, USA). All data (mean ± SE;  
n = 4) were normalized to the control (10% methanol vehicle). Non-linear, three parameter  
dose-response (variable slope) analysis was performed and EC50 values were calculated (Table 4). 
5. Conclusions 
AZP events to date have only occurred with mussels harvested in Europe, which is consistent  
with the occurrence of the AZA-producing species A. spinosum in the Northeast Atlantic. However, we 
now have evidence that other species such as A. poporum and Amphidoma languida are also  
AZA-producers [30]. Whereas A. languida, to date, has only been confirmed to occur in the Northeast 
Atlantic, we now know that A. poporum has a much wider distribution [22,28,29]. Our data suggest 
that there is a potential risk of AZP in the North West Pacific area. The lower toxicity of AZA-36 is 
probably not the only reason for the lack of AZP events in the west Pacific, but environmental factors 
that control growth and proliferation of the producing species most likely also play an important  
role [41]. For this reason we suggest that AZA-36 and AZA-37 should be included in shellfish safety 
monitoring programmes. Currently both compounds can only be quantified as AZA-1 equivalents until 
standards for these compounds are made available. Although in vitro AZA-36 and AZA-37 are 6- and 
3- fold less toxic than AZA-1, respectively, knowledge of the presence of these toxins in seafood, 
especially if associated with the presence of other shellfish toxins, is important for the health of 
shellfish consumers. Certainly more research is required to reveal the relationship between the 
occurrence of AZA-producers and AZP events. 
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